tiprankstipranks
Advertisement

MDPL - ETF AI Analysis

Compare

Top Page

MDPL

Monarch Dividend Plus ETF (MDPL)

Rating:72Outperform
Price Target:
MDPL (Monarch Dividend Plus ETF) earns a solid overall rating thanks to several high-quality core holdings like FactSet Research, Willis Towers Watson, and Brown & Brown, which bring strong financial performance, profitability, and positive earnings outlooks to the portfolio. The rating is held back somewhat by names such as General Mills, Becton Dickinson, and H&R Block, where issues like limited momentum, potential overvaluation, and high leverage introduce more uncertainty. The main risk factor is that several holdings show bearish or mixed technical trends and balance-sheet pressures, which could weigh on short-term performance even though the overall portfolio quality is sound.
Positive Factors
Dividend-Focused Strategy
The fund targets dividend-paying companies, which can provide a steadier income stream for investors over time.
Sector Diversification Across the Economy
Holdings spread across financials, technology, health care, consumer sectors, industrials, energy, and communications help reduce the impact of weakness in any single industry.
Select Strong Top Holdings
Some of the largest positions, such as UnitedHealth and Lamb Weston, have shown strong recent performance, helping support the fund’s results.
Negative Factors
High Expense Ratio
The fund’s fee is relatively high for an ETF, which can eat into long-term returns compared with lower-cost alternatives.
Heavy Tilt Toward Financial Stocks
A large share of the portfolio is in financial companies, which increases the fund’s sensitivity to problems in that sector.
Recent Performance Weakness
The ETF has shown weak performance over the past few months, with several top holdings lagging, which may signal near-term volatility or pressure on returns.

MDPL vs. SPDR S&P 500 ETF (SPY)

MDPL Summary

The Monarch Dividend Plus ETF (MDPL) tracks the Monarch Dividend Plus Index, focusing on large, established U.S. companies that pay regular dividends. It holds a mix of sectors, with a big tilt toward financials and some technology, health care, and consumer companies. Well-known holdings include UnitedHealth and Qualcomm. Investors might consider MDPL if they want a combination of potential long-term growth and a steady stream of dividend income from blue-chip stocks. A key risk is that the fund is heavily invested in large U.S. dividend payers, so its value can go up and down with that part of the market.
How much will it cost me?The Monarch Dividend Plus ETF (MDPL) has an expense ratio of 1.24%, meaning you’ll pay $12.40 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on selecting dividend-paying large-cap stocks with growth potential.
What would affect this ETF?The Monarch Dividend Plus ETF (MDPL) could benefit from stable economic growth in the U.S., as its focus on large-cap, dividend-paying companies provides resilience and income potential during periods of market stability. However, rising interest rates or economic downturns could negatively impact dividend-paying stocks, particularly in sectors like Consumer Cyclical and Technology, which are sensitive to changes in consumer spending and innovation cycles. Regulatory changes in healthcare or financial sectors, where MDPL has significant exposure, could also pose risks to its performance.

MDPL Top 10 Holdings

MDPL is leaning heavily on U.S. dividend payers, with a noticeable tilt toward financials and steady, blue-chip names. Oshkosh is one of the few bright spots, quietly rising and helping to offset a pack of laggards. On the defensive side, General Mills and Lamb Weston are more or less treading water, offering stability but not much spark. The real drag comes from health care and tech: Zoetis, Becton Dickinson, and SS&C have been losing steam, weighing on returns and making the fund feel more cautious than growthy despite its large-cap focus.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
KBR4.08%$2.37M$4.62B-22.57%
73
Outperform
Brown & Brown3.99%$2.32M$23.73B-35.41%
76
Outperform
Oshkosh3.93%$2.28M$8.90B12.90%
71
Outperform
Factset Research3.89%$2.26M$8.89B-41.90%
78
Outperform
Willis Towers Watson3.80%$2.21M$27.03B-5.71%
75
Outperform
Charles Schwab3.63%$2.11M$168.70B8.66%
74
Outperform
General Mills3.59%$2.09M$20.05B-28.43%
66
Neutral
Marsh & McLennan Companies3.56%$2.07M$86.02B-16.50%
71
Outperform
Becton Dickinson3.55%$2.07M$43.56B-10.50%
67
Neutral
Ameriprise Financial3.54%$2.06M$43.97B-5.27%
64
Neutral

MDPL Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
25.87
Positive
100DMA
25.92
Positive
200DMA
26.16
Negative
Market Momentum
MACD
0.03
Negative
RSI
55.85
Neutral
STOCH
78.66
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MDPL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 25.47, equal to the 50-day MA of 25.87, and equal to the 200-day MA of 26.16, indicating a neutral trend. The MACD of 0.03 indicates Negative momentum. The RSI at 55.85 is Neutral, neither overbought nor oversold. The STOCH value of 78.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MDPL.

MDPL Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$57.97M1.19%
72
Outperform
$97.16M0.45%
69
Neutral
$96.55M0.80%
67
Neutral
$93.97M0.35%
73
Outperform
$92.27M0.93%
63
Neutral
$88.28M0.49%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MDPL
Monarch Dividend Plus ETF
26.05
0.09
0.35%
ACEP
ARS Core Equity Portfolio ETF
FCUS
Pinnacle Focused Opportunities ETF
JOYT
JPMorgan Equity and Options Total Return ETF
EGGQ
NestYield Visionary ETF
JHDG
John Hancock Hedged Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement